Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.
Gleich GJ, Roufosse F, Chupp G, Faguer S, Walz B, Reiter A, Yancey SW, Bentley JH, Steinfeld J; HES Mepolizumab Study Group. Gleich GJ, et al. Among authors: faguer s. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4431-4440.e1. doi: 10.1016/j.jaip.2021.07.050. Epub 2021 Aug 10. J Allergy Clin Immunol Pract. 2021. PMID: 34389506 Free article. Clinical Trial.
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.
Rothenberg ME, Roufosse F, Faguer S, Gleich GJ, Steinfeld J, Yancey SW, Mavropoulou E, Kwon N; HES Mepolizumab Study Group. Rothenberg ME, et al. Among authors: faguer s. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2367-2374.e3. doi: 10.1016/j.jaip.2022.04.037. Epub 2022 May 12. J Allergy Clin Immunol Pract. 2022. PMID: 35568330 Free article. Clinical Trial.
Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit.
Gaillet A, Bay P, Péju E, Ait-Oufella H, Azoulay E, Benchabane N, Cerf C, Cohen Y, de Prost N, Faguer S, Geri G, Grangé S, Kahn JE, Kreitmann L, Larcher R, Lefèvre G, Mabrouki A, Mekonsto-Dessap A, Panel K, Pène F, Pineton de Chambrun M, Quenot JP, Tandjaoui-Lambiotte Y, Timsit JF, Vieillard-Baron A, Dargent A, Herault A, Groh M. Gaillet A, et al. Among authors: faguer s. Intensive Care Med. 2023 Mar;49(3):291-301. doi: 10.1007/s00134-022-06967-9. Epub 2023 Feb 1. Intensive Care Med. 2023. PMID: 36723637
Correction: Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit.
Gaillet A, Bay P, Péju E, Ait-Oufella H, Azoulay E, Benchabane N, Cerf C, Cohen Y, de Prost N, Faguer S, Geri G, Grangé S, Kahn JE, Kreitmann L, Larcher R, Lefèvre G, Mabrouki A, Mekonsto-Dessap A, Panel K, Pène F, Pineton de Chambrun M, Quenot JP, Tandjaoui-Lambiotte Y, Timsit JF, Vieillard-Baron A, Dargent A, Herault A, Groh M. Gaillet A, et al. Among authors: faguer s. Intensive Care Med. 2023 May;49(5):611. doi: 10.1007/s00134-023-07059-y. Intensive Care Med. 2023. PMID: 37042964 No abstract available.
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M, Rohmer J, Etienne N, Abou Chahla W, Baudet A, Chan Hew Wai A, Chenivesse C, Clisson Rusek I, Cottin V, Decamp M, De Groote P, Delahousse F, Duployez N, Faguer S, Gottrand F, Huang F, Leblanc T, Magnan A, Martin T, Mortuaire G, Néel A, Paris L, Petit A, Rossignol J, Schleinitz N, Soret-Dulphy J, Staumont-Salle D, Terrier B, Terriou L, Viallard JF, Lefèvre G, Kahn JE. Groh M, et al. Among authors: faguer s. Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4. Orphanet J Rare Dis. 2023. PMID: 37122022 Free PMC article.
The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease).
Pineton de Chambrun M, Moyon Q, Faguer S, Urbanski G, Mathian A, Zucman N, Werner M, Luyt CE, Verlicchi F, Amoura Z; EurêClark Study Group. Pineton de Chambrun M, et al. Among authors: faguer s. J Allergy Clin Immunol Pract. 2022 Feb;10(2):626-629. doi: 10.1016/j.jaip.2021.11.023. Epub 2021 Dec 7. J Allergy Clin Immunol Pract. 2022. PMID: 34890829 Free PMC article. No abstract available.
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial.
Zafrani L, Canet E, Walter-Petrich A, Joly-Laffargue B, Veyradier A, Faguer S, Bigé N, Calvet L, Mayaux J, Grangé S, Rafat C, Poulain C, Klouche K, Perez P, Pène F, Pichereau C, Duceau B, Mariotte E, Chevret S, Azoulay E. Zafrani L, et al. Among authors: faguer s. Intensive Care Med. 2023 Nov;49(11):1293-1304. doi: 10.1007/s00134-023-07178-6. Epub 2023 Oct 23. Intensive Care Med. 2023. PMID: 37867165 Clinical Trial.
Performances of acute kidney injury biomarkers vary according to sex.
Faguer S, Piedrafita A, Sanz AB, Siwy J, Mina IK, Alves M, Bousquet P, Marcheix B, Casemayou A, Klein J, Minville V, Breuil B, Ortiz A, Schanstra JP. Faguer S, et al. Clin Kidney J. 2024 Mar 27;17(5):sfae091. doi: 10.1093/ckj/sfae091. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38699482 Free PMC article.
Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis.
Razazi K, Luyt CE, Voiriot G, Rouzé A, Garnier M, Ferré A, Camous L, Heming N, Lapidus N, Charles-Nelson A, Mekontso-Dessap A; COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Razazi K, et al. Crit Care. 2024 Apr 20;28(1):131. doi: 10.1186/s13054-024-04906-2. Crit Care. 2024. PMID: 38641851 Free PMC article.
190 results